• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向肯尼亚多发性骨髓瘤治疗的统一方法——首届多发性骨髓瘤大会会议记录。

Towards a unified approach for multiple myeloma care in Kenya - proceedings of the Inaugural Multiple Myeloma Congress.

机构信息

School of Medicine, Moi University, Eldoret, Kenya.

Academic Model Providing Access To Healthcare (AMPATH) Oncology Institute, Eldoret, Kenya.

出版信息

Pan Afr Med J. 2021 Dec 17;40:236. doi: 10.11604/pamj.2021.40.236.30742. eCollection 2021.

DOI:10.11604/pamj.2021.40.236.30742
PMID:35178147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8817190/
Abstract

The rising burden of multiple myeloma in Kenya has not been met by a commensurate effort for control. Patients and practitioners struggle with unavailability and unaffordability of diagnostics, drugs and stem cell transplant leading to presentation at advanced stages and under-treatment with increased morbidities and mortality. A concerted effort among stakeholders is urgently needed to develop strategies for myeloma control. The scarcity of providers also carries grave consequences for Kenyan patients. The Academic Model Providing Access To Healthcare (AMPATH) multiple myeloma program organized the Inaugural Virtual Multiple Myeloma Congress to achieve both interactive specialist instruction and stakeholder engagement. Expert presenters and panellists from diverse disciplines were invited to offer in-depth presentations on myeloma care and case studies from panellists´ practice were used to contextualize learning points and form a basis for generating debate on the challenges facing providers and opportunities for care improvement. An audience of health professionals offering care to myeloma patients was invited. The underlying principle of recommendations developed during the congress was collaboration among in-country and international practitioners, researchers and policy experts from private and public sector. This partnership of stakeholders bears the potential of pooling scarce resources and for collective advocacy towards better patient care.

摘要

肯尼亚多发性骨髓瘤负担不断加重,但控制工作却没有相应增加。患者和医生难以获得诊断、药物和干细胞移植,导致疾病处于晚期,治疗不足,发病率和死亡率增加。利益攸关方迫切需要共同努力,制定多发性骨髓瘤控制策略。提供者的稀缺也给肯尼亚患者带来了严重后果。学术模式提供医疗保健机会(AMPATH)多发性骨髓瘤项目组织了第一届虚拟多发性骨髓瘤大会,以实现互动专家指导和利益攸关方参与。邀请了来自不同学科的专家演讲者和小组成员,就骨髓瘤护理进行深入介绍,并使用小组成员的案例研究来使学习要点具体化,并为讨论提供者面临的挑战和改善护理的机会提供基础。邀请了为骨髓瘤患者提供护理的卫生专业人员参加。大会期间制定的建议的基本原则是,国内和国际从业者、研究人员以及来自私营和公共部门的政策专家之间的合作。这种利益攸关方的伙伴关系有可能汇集稀缺资源,并进行集体宣传,以改善患者护理。

相似文献

1
Towards a unified approach for multiple myeloma care in Kenya - proceedings of the Inaugural Multiple Myeloma Congress.迈向肯尼亚多发性骨髓瘤治疗的统一方法——首届多发性骨髓瘤大会会议记录。
Pan Afr Med J. 2021 Dec 17;40:236. doi: 10.11604/pamj.2021.40.236.30742. eCollection 2021.
2
Expanding Myeloma Training and Care in Western Kenya Through the ECHO Model: The Pilot Phase.通过 ECHO 模式在肯尼亚西部扩大多发性骨髓瘤培训和护理:试点阶段。
JCO Glob Oncol. 2024 Apr;10:e2300416. doi: 10.1200/GO.23.00416.
3
Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya.在肯尼亚西部建立一个可持续的多发性骨髓瘤综合项目。
JCO Glob Oncol. 2021 Mar;7:400-407. doi: 10.1200/GO.20.00572.
4
Leveraging the power of partnerships: spreading the vision for a population health care delivery model in western Kenya.利用伙伴关系的力量:在肯尼亚西部传播全民医疗保健提供模式的愿景。
Global Health. 2018 May 8;14(1):44. doi: 10.1186/s12992-018-0366-5.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Strategies for Effective Stakeholder Engagement in Strengthening Referral Networks for Management of Hypertension Across Health Systems in Kenya.在肯尼亚的卫生系统中加强高血压管理的转介网络,有效利益相关者参与策略。
Glob Heart. 2019 Jun;14(2):173-179. doi: 10.1016/j.gheart.2019.06.003.
7
Addressing Care Continuity and Quality Challenges in the Management of Hypertension: Case Study of the Private Health Care Sector in Kenya.解决高血压管理中的连续性和质量挑战:肯尼亚私立医疗保健部门的案例研究。
J Med Internet Res. 2021 Feb 17;23(2):e18899. doi: 10.2196/18899.
8
Strengthening community and stakeholder participation in the implementation of integrated vector management for malaria control in western Kenya: a case study.加强肯尼亚西部社区和利益相关者参与综合病媒管理以控制疟疾的实施:案例研究。
Malar J. 2021 Mar 19;20(1):155. doi: 10.1186/s12936-021-03692-4.
9
Value of stakeholder engagement in improving newborn care in Kenya: a qualitative description of perspectives and lessons learned.利益相关者参与改善肯尼亚新生儿护理的价值:观点和经验教训的定性描述。
BMJ Open. 2021 Jun 30;11(6):e045123. doi: 10.1136/bmjopen-2020-045123.
10
The joint 15th Pan-African Society of Cardiology and Kenya Cardiac Society congress proceedings, 2021.2021 年第 15 届泛非心脏病学会和肯尼亚心脏病学会联合大会会议记录
Cardiovasc J Afr. 2022 Mar-Apr;33(2):88-94. doi: 10.5830/CVJA-2022-020.

本文引用的文献

1
Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya.在肯尼亚西部建立一个可持续的多发性骨髓瘤综合项目。
JCO Glob Oncol. 2021 Mar;7:400-407. doi: 10.1200/GO.20.00572.
2
CAR T cell therapies for patients with multiple myeloma.嵌合抗原受体 T 细胞疗法治疗多发性骨髓瘤患者。
Nat Rev Clin Oncol. 2021 Feb;18(2):71-84. doi: 10.1038/s41571-020-0427-6. Epub 2020 Sep 25.
3
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.种族与多发性骨髓瘤的治疗模式和生存结局的关联:Connect MM 注册分析。
Cancer. 2020 Oct 1;126(19):4332-4340. doi: 10.1002/cncr.33089. Epub 2020 Jul 24.
4
Landscape of Oncology Clinical Trials in Africa.非洲肿瘤学临床试验概况
JCO Glob Oncol. 2020 Jun;6:932-941. doi: 10.1200/JGO.19.00189.
5
Oncology Clinical Trials in Africa: Emerging and Operational Issues.非洲的肿瘤学临床试验:新出现的问题与实施问题
JCO Glob Oncol. 2020 Jun;6:929-931. doi: 10.1200/GO.20.00233.
6
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.达雷妥尤单抗、来那度胺、硼替佐米和地塞米松用于适合移植的新诊断多发性骨髓瘤:GRIFFIN 试验。
Blood. 2020 Aug 20;136(8):936-945. doi: 10.1182/blood.2020005288.
7
A review of Kenya's cancer policies to improve access to cancer testing and treatment in the country.肯尼亚癌症政策回顾:提高该国癌症检测和治疗的可及性。
Health Res Policy Syst. 2020 Jan 7;18(1):2. doi: 10.1186/s12961-019-0506-2.
8
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial.达雷妥尤单抗联合硼替佐米、美法仑和泼尼松治疗新诊断多发性骨髓瘤(ALCYONE)的总生存:一项随机、开放标签、3 期临床试验。
Lancet. 2020 Jan 11;395(10218):132-141. doi: 10.1016/S0140-6736(19)32956-3. Epub 2019 Dec 10.
9
Overcoming Barriers in the Implementation of Programs for Breast and Cervical Cancers in Cali, Colombia: A Pilot Model.克服哥伦比亚卡利市乳腺癌和宫颈癌项目实施中的障碍:一个试点模式
J Glob Oncol. 2019 Jul;5:1-9. doi: 10.1200/JGO.19.00054.
10
Presentation and survival of multiple myeloma patients in Ghana: a review of 169 cases.加纳多发性骨髓瘤患者的临床表现与生存情况:169例病例回顾
Ghana Med J. 2019 Mar;53(1):52-58. doi: 10.4314/gmj.v53i1.8.